Evaluation of anti-inflammatory drugs based upon the inhibition of matrix-induced ornithine decarboxylase activity during connective tissue proliferation.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001681:Biological Assay / Q000379:methods*; D001857:Bone Matrix; D002262:Carboxy-Lyases / Q000378:metabolism*; D003238:Connective Tissue / Q000201:enzymology*; D003239:Connective Tissue Cells; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005938:Glucocorticoids / Q000494:pharmacology; D008297:Male; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D051381:Rats
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D002262:Carboxy-Lyases; D009955:Ornithine Decarboxylase